FDG PET biomarkers for prediction of survival in metastatic melanoma prior to anti-PD1 immunotherapy.
Adult
Aged
Aged, 80 and over
Biomarkers
Female
Fluorodeoxyglucose F18
Humans
Immunotherapy
/ methods
Male
Melanoma
/ diagnostic imaging
Middle Aged
Positron Emission Tomography Computed Tomography
Programmed Cell Death 1 Receptor
/ immunology
Retrospective Studies
Risk Assessment
Survival Analysis
Tumor Burden
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
22 09 2021
22 09 2021
Historique:
received:
17
05
2021
accepted:
31
08
2021
entrez:
23
9
2021
pubmed:
24
9
2021
medline:
18
12
2021
Statut:
epublish
Résumé
Our aim was to analyse whether biomarkers extracted from baseline
Identifiants
pubmed: 34552135
doi: 10.1038/s41598-021-98310-3
pii: 10.1038/s41598-021-98310-3
pmc: PMC8458464
doi:
Substances chimiques
Biomarkers
0
PDCD1 protein, human
0
Programmed Cell Death 1 Receptor
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
18795Informations de copyright
© 2021. The Author(s).
Références
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):930-939
pubmed: 30488098
Ann Nucl Med. 2020 Dec;34(12):968-974
pubmed: 33070295
J Clin Invest. 2017 Aug 1;127(8):2930-2940
pubmed: 28650338
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2298-2310
pubmed: 31346755
Eur Radiol. 2019 Jun;29(6):3183-3191
pubmed: 30645669
Nuklearmedizin. 2020 Jun;59(3):228-234
pubmed: 32259852
Clin Radiol. 2019 Jun;74(6):467-473
pubmed: 30898382
Nature. 2014 Nov 27;515(7528):563-7
pubmed: 25428504
J Nucl Med. 2015 Jan;56(1):38-44
pubmed: 25500829
PLoS One. 2015 Dec 15;10(12):e0145063
pubmed: 26669541
Expert Opin Biol Ther. 2017 Jun;17(6):735-746
pubmed: 28318336
JAMA. 2016 Apr 19;315(15):1600-9
pubmed: 27092830
J Nucl Med. 2020 Jun;61(6):814-820
pubmed: 31732678
EJNMMI Res. 2017 Dec;7(1):60
pubmed: 28748524
Cancer Immunol Immunother. 2020 Jun;69(6):927-936
pubmed: 32076793
J Nucl Med. 2018 Aug;59(8):1321-1328
pubmed: 29301932
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
Mol Imaging Biol. 2021 Oct;23(5):756-765
pubmed: 33763816
Mol Cancer. 2012 Oct 09;11:76
pubmed: 23043612
N Engl J Med. 2015 Jan 22;372(4):320-30
pubmed: 25399552
Ann Oncol. 2016 Aug;27(8):1492-504
pubmed: 27207108
Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2790-2799
pubmed: 31482428
Cell. 2016 Mar 24;165(1):35-44
pubmed: 26997480
Radiology. 2020 May;295(2):328-338
pubmed: 32154773
PLoS One. 2011 Feb 28;6(2):e17238
pubmed: 21386892
Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):151-165
pubmed: 27271051
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
J Nucl Med. 2014 Jun;55(6):891-7
pubmed: 24752672
Acta Oncol. 2010 Oct;49(7):1012-6
pubmed: 20831489
J Nucl Med. 2014 Mar;55(3):414-22
pubmed: 24549286
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
N Engl J Med. 2018 May 31;378(22):2093-2104
pubmed: 29658845
Cancer Res. 2018 Aug 15;78(16):4786-4789
pubmed: 29959149
Cancer Treat Rev. 2015 Dec;41(10):868-76
pubmed: 26589760
J Nucl Med. 2004 Sep;45(9):1431-4
pubmed: 15347707
Phys Med Biol. 2020 Jan 13;65(1):015010
pubmed: 31835261
AJR Am J Roentgenol. 2019 Apr 1;:1-9
pubmed: 30933647
Front Oncol. 2018 May 29;8:178
pubmed: 29896449